CDCinta de Diego

Cinta de Diego

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cinta de Diego has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia

    by Angel Vila-Corcoles, Ferran Bejarano-Romero, Elisabeth Salsench, Olga Ochoa-Gondar, Cinta de Diego, Frederic Gomez-Bertomeu, Xavier Raga-Luria, Xavier Cliville-Guasch, Victoria Arija

    Pneumococcal diseases remain a major cause of morbidity and mortality worldwide. Updated data on drug-resistance from different populations may be important to recognize changes in disease patterns. This study assessed current levels of penicilin resistance among Streptococcus Pneumoniae causing pneumonia in Spanish middle age and older adults.


  • Open Access

    The burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 Study

    by Olga Ochoa-Gondar, Angel Vila-Córcoles, Cinta de Diego, Victoria Arija, Monica Maxenchs, Montserrat Grive, Enrique Martin, Josep L Pinyol

    Community-acquired pneumonia (CAP) is generally considered a major cause of morbidity and mortality in the elderly. However, population-based data are very limited and its overall burden is unclear. This study assessed incidence and mortality from CAP among Spanish community-dwelling elderly.


  • Open Access

    Effects of annual influenza vaccination on winter mortality in elderly people with chronic heart disease

    by Cinta de Diego, Angel Vila-Córcoles, Olga Ochoa, Teresa Rodriguez-Blanco, Elisabeth Salsench, Imma Hospital, Ferran Bejarano, M. del Puy Muniain, Mercé Fortin, Montserrat Canals, et al.

    Although there is general agreement for the recommendation of the influenza vaccine to elderly and high-risk adults, the magnitude of clinical effectiveness and benefit from the annual vaccination is controversial. In this study, we have assessed the effects of annual influenza vaccination on winter mortality in older adults with chronic heart disease. Cohort study that included 1340 Spanish community-dwelling individuals 65 years or older who had chronic heart disease (congestive heart failure or coronary artery disease) followed from January 2002 to April 2005. Annual influenza vaccine status was a time-varying condition and primary outcome was all-cause death during the study period. Multivariable Cox proportional-hazard models adjusted by age, sex, and comorbidity were used to evaluate vaccine effectiveness. Influenza vaccination was associated with a significant reduction of 37% in the adjusted risk of winter mortality during the overall period 2002–2005. The attributable mortality risk reduction in vaccinated people was 8.2 deaths per 1000 person-winters. We estimated that one death was prevented for every 122 annual vaccinations (ranging between 49 in Winter 2005 and 455 in Winter 2003). Our results suggest a benefit from the influenza vaccination and support an annual vaccination strategy for elderly people with cardiac diseases.